International Society of Hypertension

ISH - Hero Image 1ISH - Hero Image 2ISH - Hero Image 3ISH - Hero Image 6ISH - Hero Image 8Suported by MedtronicISH - Hero Image 9ISH - Hero Image 14ISH - Hero Image 15ISH - Hero Image 16ISH - Hero Image 17ISH - Hero Image 18Suported by OmronISH - Hero Image 19ISH - Hero Image 20ISH - Hero Image 21ISH - Hero Image 22ISH - Hero Image 23Suported by Servier

What's On My Desk

ISH network logo

Global leaders in hypertension and cardiovascular research share with us the details of research articles currently of interest to them or their motivational contributions not necessarily of a scientific nature.

During 04/2019

  • Dr Daniel Piskorz

    Dr. Daniel Piskorz was the 2011 – 2013 President of the Argentina Hypertension Society and the 2017 President of the Argentina Cardiology Federation, and has been a member of the Board of Directors of the Latin-American Hypertension Society since 2013. He is currently the Chief of the Cardiovascular Research Center at Rosario British Sanatorium and Board of Directors of the Cardiology Institute at Rosario British Sanatorium.

    Urine Haptoglobin and Haptoglobin-Related Protein Predict Response to Spironolactone in Patients with Resistant Hypertension.

    Resistant hypertension double the risk of end stage renal disease, increase by almost 60 % the risk of stroke and 45 % of coronary artery disease, and enhance by approximately 30 % the mortality (Muntner P. Hypertension 2014; 64: 1012 - 1021.).

    Read More 05/04/2019

Latest Tweets:

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.